Cleft lip and cleft palate, collectively referred to as orofacial clefts, are among the most common craniofacial birth defects in the United States. A new study led by ADA Forsyth adjunct faculty Dr. Eric Kang Ting suggests a cutting-edge therapeutic approach using fibromodulin, a molecule that regulates myofibroblasts at the site of tissue closure, may mitigate or even prevent excessive scarring following surgical orofacial cleft repair, significantly advancing the field of wound healing and regeneration.